Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH.
about
Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study.Evaluation of apoptosis indexes in currently used oral alpha-blockers in prostate: a pilot study.
P2860
Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Open-label, 9-month extension ...... with LUTS associated with BPH.
@en
Open-label, 9-month extension ...... with LUTS associated with BPH.
@nl
type
label
Open-label, 9-month extension ...... with LUTS associated with BPH.
@en
Open-label, 9-month extension ...... with LUTS associated with BPH.
@nl
prefLabel
Open-label, 9-month extension ...... with LUTS associated with BPH.
@en
Open-label, 9-month extension ...... with LUTS associated with BPH.
@nl
P2093
P2860
P1476
Open-label, 9-month extension ...... with LUTS associated with BPH.
@en
P2093
Andreas Eisenhardt
Christopher R Chapple
Matthias Oelke
Nadir I Osman
Teuvo L Tammela
P2860
P2888
P304
P356
10.1007/S00345-015-1519-2
P577
2015-02-25T00:00:00Z